Paragon Genomics: Paragon Applies Amplicon Panels for Targeted Sequencing To COVID-19
Bio-IT World | A key question for life sciences companies in the past few months has been how dramatically to respond to the COVID-19 pandemic. Paragon Genomics, based in Hayward, California, believes their amplicon-based target enrichment technology for targeted sequencing provides an answer.
Read full article »
Paragon Genomics develops advanced target enrichment methods and reagent kits for the next generation sequencing and precision medicine markets.
Read more